- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04654013
PROductivity Study of Presbyopia Elimination in Rural-dwellers III (PROSPERIII)
Effects of Near Vision Spectacle Correction on Work Retention Among Textile Factories Workers in India
Study Overview
Detailed Description
Globally, 1.1 billion people lack a simple pair of reading glasses to correct impaired near vision, called presbyopia. Presbyopia can begin as early as age 30 years, commonly becomes functionally apparent by 40, and is essentially complete by 55 meaning that presbyopia is most common at the height of the working years. The global productivity loss due to uncorrected presbyopia has been estimated to exceed US$25 billion, and presbyopia is shown to be associated with significant impairment in activities of daily living. There is paucity in trial evidence of the impact on near vision spectacle correction on work productivity and workplace retention. The largest reported effect sizes among such trials (specifically for productivity) was the PROSPER trial, which showed that providing inexpensive near vision glasses increased the daily weight of tea picked among presbyopic, mostly-female Indian agricultural workers by more than 5 kg (21.7%) compared to those in the control group.
Study Plan: The investigators will choose 1260 textile workers aged 30 years and above with uncorrected presbyopia who are employed by Shahi Exports Private Limited in Karnataka, India. They will be randomly assigned into one of two groups: a group receiving free reading glasses within one week of undergoing vision assessment ("Intervention") or a group receiving identical reading glasses at the end of the assessment period ("Control").The main study outcome will be the proportion of workers who continue working at the factories in the intervention group (as opposed to control). The investigators anticipate that the glasses intervention will increase retention by 20% in the Intervention group at 1 year.
The study will also assess the workers' efficiency, why they have left employment, how satisfied and valued they felt at their work and how often they use their glasses for work. These other outcomes will help the investigators to better understand the causal pathway between vision and work retention. The investigators will also study the total cost of providing glasses per additional worker retain their employment.
Research question: Will providing free glasses to presbyopic Indian textile workers increase work retention?
Design: Investigator-masked, multi-center randomized controlled trial with a qualitative component
Rationale: Although presbyopia is safely, effectively and inexpensively treated with glasses, rates of optical correction in LMICs are as low as 10%. The way in which firms manage workers has profound implications for performance by way of worker attendance, retention, and productivity. Similarly, worker engagement, and the extent to which workers feel valued, is a key determinant of firm performance. As the low-skill workforce in many developing countries transitions rapidly from agriculture to industrial work, employers struggle with high worker turnover due to poor working conditions, low pay, and restricted worker rights. Few trials have been published which address the question of whether healthcare interventions can improve work performance as well as workplace retention, especially among persons over the age of 40 in low and middle-income countries (LMICs). There is interest in understanding if these results obtained in an agricultural setting can be extended to other financially-important sectors.
Methods: The investigators will choose 1260 textile workers aged 30 years and above with uncorrected presbyopia who are employed by Shahi Exports Private Limited in Karnataka, India. They will be randomly assigned into one of two groups: a group receiving free reading glasses within one week of undergoing vision assessment ("Intervention") or a group receiving identical reading glasses at the end of the assessment period ("Control").
The main outcome 18 month later will be work retention; secondary outcomes are workers' efficiency, the reasons the workers left their employment, satisfaction and perceived self-valued at work and glasses wear adherence at work. Attitudes about presbyopia and spectacle use and intervention cost-effectiveness will be studied.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Karantaka
-
Bengaluru, Karantaka, India, 560102
- Good Business Lab
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 30 years and above
- Distance visual acuity >= 6/12 in both eyes
- Presence of presbyopia, defined as the inability, correctable with reading glasses, to read the N8 line using both eyes together, on a tumbling near vision chart at a distance of 25cm, 30cm, 40cm, and 50cm based on workers working distance
- Employed at the factory for >=3months in the sewing department
Exclusion Criteria:
- Current ownership of reading or distance glasses (regardless of accuracy)
- Obvious evidence of ocular disease in either eye detected during the eye examination, or history of such disease based on self-report
- Low likelihood of completing follow-up in the study due to current plans to move out of the area or leave employment at Shahi during the follow-up period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Workers assigned to the intervention group will receive free spectacles of a design they select, based on the worker's measured refractive power and dispensed one week later at the factory by the study ophthalmic personnel.
|
Intervention group workers receive free glasses within one week of undergoing vision assessment (May 2022).
The duration of the treatment for the Intervention participants will depend on when they leave employment at the factor.
If they stayed for the full duration of the trial, they will have undergone a maximum of 18 months (December 2023).
Other Names:
|
No Intervention: Control
Workers assigned to the Control group will receive similar free glasses at the end of the study assessment (18 months).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Work retention
Time Frame: September 2022 to May 2024; Over the 18 month follow-up period from enrolment to study completion
|
Proportion of textile workers who continue to work at the textile factories assessed from trial entry to closure as recorded in Shahi's Human Resource Management Database
|
September 2022 to May 2024; Over the 18 month follow-up period from enrolment to study completion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compliance with spectacle wear
Time Frame: 3, 6, 9, 12, 15 and 18 months after enrolment
|
Actual presence of spectacles on the worker's face at work as reported by supervisor at the time of unannounced observation
|
3, 6, 9, 12, 15 and 18 months after enrolment
|
Change in work satisfaction
Time Frame: Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
|
Proportion of sew-ers who state they are satisfied or very satisfied with work, feel valued or very valued at work, and are likely or very likely to stay with Shahi
|
Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
|
Change in feeling valued-at-work
Time Frame: Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
|
Proportion of sew-ers who state they feel valued or very valued working at Shahi
|
Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
|
Change in likeliness to stay at work
Time Frame: Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
|
Proportion of sew-ers who state they are likely or very likely to stay with Shahi
|
Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
|
Change in work efficiency
Time Frame: Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
|
Self-assessed productivity scores using the Cantril's Ladder, with the best possible score being a 10, and the worst being a 0.
|
Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
|
Attitudes towards vision correction
Time Frame: At month 0
|
Worker's self-reported attitudes towards vision correction
|
At month 0
|
Access to local eyecare services
Time Frame: At month 0
|
Worker's self-reported access to local eyecare services
|
At month 0
|
History of uptake of eyecare services
Time Frame: At month 0
|
Worker's self-reported history of uptake of eyecare services
|
At month 0
|
Change in Quality of Life as assessed by the THRIVE Near Vision Quality of Life tool
Time Frame: Between baseline and endline at 18 months
|
Self-reported quality of life scores measured with the modified THRIVE Near Vision Quality of Life tool, a Likert Scale ranging from 1 (least affected) to 5 (worst affected).
|
Between baseline and endline at 18 months
|
Reasons leaving employment at Shahi
Time Frame: 2 months within participants leaving employment
|
Reasons given by the former supervisor and colleagues of former sew-ers for workers no longer being employed at Shahi
|
2 months within participants leaving employment
|
Change in work productivity
Time Frame: Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
|
Proportion of target production realized by a worker per unit time.
|
Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
|
Cost effectiveness of intervention
Time Frame: At study closeout at 18 months
|
Ratio of incremental program cost to additional workers in the intervention group who retain employment vs. those in the control group.
Incremental cost is the difference of program costs between implementation of intervention and control (not including study costs, such as data collection).
|
At study closeout at 18 months
|
Change in skill grade
Time Frame: Between baseline and endline at 18 months
|
Worker's skill grade as reported by supervisor.
|
Between baseline and endline at 18 months
|
Change in monthly wage
Time Frame: Between baseline and endline at 18 months
|
Worker's monthly wage as reported by supervisor.
|
Between baseline and endline at 18 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nathan G Congdon, MD, MPH, Queen's University, Belfast
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MHLS 20_84
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
Lee, Steven, M.D.CompletedMyopia, | Hyperopia, | Astigmatism, | Presbyopia, | Eye Strain,
-
Allotex, Inc.RecruitingPresbyopiaCzechia, Ireland, Turkey, United Kingdom
-
Coopervision, Inc.Centre for Ocular Research & Education, CanadaRecruitingPresbyopiaUnited States, Canada
-
Optall VisionRecruiting
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.LENZ Therapeutics, IncCompleted
-
Allotex, Inc.TerminatedPresbyopiaBelgium, Ireland, United Kingdom
-
Coopervision, Inc.CORECompletedPresbyopiaUnited States, Canada
Clinical Trials on Spectacles
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUnknown
-
Johns Hopkins UniversityNational Health and Medical Research Council, AustraliaCompletedAstigmatism | Myopia | HyperopiaChina, India
-
Essilor InternationalQueensland University of TechnologyCompleted
-
Shanghai Eye Disease Prevention and Treatment CenterBrien Holden VisionRecruitingBlindness,Visual Impairment, Refractive Error, Cataract, High Myopia, AgingChina
-
Coopervision, Inc.CompletedAmetropiaUnited Kingdom
-
Avulux, Inc.Completed
-
London School of Hygiene and Tropical MedicineBritish Council for Prevention of Blindness; Tanzanian Society for the BlindCompletedUnder- and Uncorrected Significant Refractive ErrorsTanzania
-
Centre for Eye and Vision ResearchThe Hong Kong Polytechnic University; University of WaterlooRecruiting
-
Queen's University, BelfastUniversity of Ulster; University of Zimbabwe; L.V. Prasad Eye Institute; Clearly; New England College of Optometry and other collaboratorsCompletedHyperopia | Long SightZimbabwe